Skip to main content
. 2017 May 5;7(1):101–106. doi: 10.5005/jp-journals-10018-1226

Table 3: Comparison between groups I and II as regards laboratory findings after treatment

Variables      Group I after (n = 15)      Group II after (n = 15)      p-value     
Hemoglobin (g/dL)      13.20 ± 0.85      13.67 ± 0.71      0.108     
WBCs (× 103/mm3)      6.79 ± 1.70      7.36 ± 1.67      0.366     
Platelet count (× 103/mm3)      298.40 ± 76.37      309.26 ± 70.02      0.688     
Protein (g/dL)      7.47 ± 0.77      7.42 ± 0.80      0.857     
Albumin (g/dL)      4.58 ± 0.45      4.66 ± 0.41      0.493     
TSB (mg/dL)      0.87 ± 0.37      0.88 ± 0.37      0.967     
DSB (mg/dL)      0.11 ± 0.04      0.12 ± 0.05      0.613     
ALT (U/L)      46.10 ± 20.75      82.53 ± 10.41      <0.001     
AST (U/L)      38.20 ± 11.58      55.86 ± 5.11      0.03     
Serum creatinine (mg/dL)      0.89 ± 0.26      0.91 ± 0.20      0.142     
BUN (mg/dL)      17.73 ± 6.13      18.46 ± 6.45      0.752     

WBC: While blood cell; TSB: Total serum bilirubin; DSB: Direct serum bilirubin; BUN: Blood urea nitrogen